For up to eight months, Regeneron’s antibody medication protects against Covid Clinical trials have found that just one dose of the treatment significantly reduced infection risk from Covid by 81.6%. Immunocompromised patients may benefit from … Continue reading For up to eight months, Regeneron’s antibody medication protects against Covid